Collgard Biopharmaceuticals Ltd.

Collgard Biopharmaceuticals is a company that focuses on developing drug treatments that directly impact the tissue regeneration process to target disease progression. Collgard is currently developing therapeutic solutions for several clinical indications with significant unmet clinical needs, including vascular restenosis, end-organ fibrosis, selected cancers, and dermal fibroproliferative disorders. Founded in 1996, Collgard Biopharmaceuticals is a privately held, clinical stage company with a global team of medical and drug development experts based in Atlanta and Tel Aviv. They have scientific and clinical collaborations with institutions such as The Mayo Clinic, the U.S. NCI, the EORTC, and Harvard Medical School.